Anti-itching drug clemizole displays promise against hepatitis C The fight the liver disease hepatitis C has been at something of an impasse for a long time, with more than 150 million people currently infected, and traditional antiviral treatments causing nasty side effects and falling brief of a remedy often. Using a novel technique, medical and engineering researchers at Stanford University can see a vulnerable part of the virus’ reproduction procedure that in lab testing could be successfully targeted with an obsolete antihistamine www .

sildenafil by cipla

It compared up to 2.5 years of treatment with prasugrel 10 mg daily vs. Clopidogrel 75 mg daily, both in combination with aspirin, in ACS patients who were younger than age 75 years. The prasugrel dose was reduced to 5 mg daily for patients weighing less than 60 kilograms. A secondary analysis also looked at patients who had been age 75 years or old who received 5 mg of prasurgrel daily vs. Clopidogrel 75 mg daily because TRITON demonstrated an increased risk of main bleeding in these patients when they had been treated with prasugrel 10mg daily. After a median of 17 months of follow up, the principal end point – described as the time to 1st occurrence of death, heart attack or stoke – happened in 13.9 % of patients under age 75 years vs.